Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
The Cancer Letter's weekly podcast of interviews, discussions, and more to dig deep into the issues that shape oncology.
New episodes every Wednesday.
SUBSCRIBE ON
Spotify Apple Podcast YouTube
Spotify Apple Podcast YouTube
on air
As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
Podcast

As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon

May 27, 2026
The Cancer History Project debuts first de novo book; meanwhile, FDA snafus continue
Podcast

The Cancer History Project debuts first de novo book; meanwhile, FDA snafus continue

May 20, 2026
“Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
Cancer History ProjectFreePodcast

“Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process

May 15, 2026
Vol.52 No.19
By Claire Marie Porter
Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)
Podcast

Prasad’s “deceit,” plus, ODAC’s tough decision against biomarker-based progression assessment (for now)

May 13, 2026
Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time
Podcast

Reforms pending at USPSTF, plus, FDA rejects promising melanoma drug for the second time

May 06, 2026
On the joys of reporting on art as a tool for cancer education
Podcast

On the joys of reporting on art as a tool for cancer education

April 30, 2026
The Directors: UPMC’s Byrd and Jefferson’s Chapman speak about avoiding catastrophism and using bridge funding to keep labs open
PodcastThe Directors

The Directors: UPMC’s Byrd and Jefferson’s Chapman speak about avoiding catastrophism and using bridge funding to keep labs open
“There’s a tightening of the belt, and when the belt gets tightened, it has downstream effects.”

April 24, 2026
Vol.52 No.16
By Claire Marie Porter and Paul Goldberg
No need for a speculum? A new era of HPV screening
Podcast

No need for a speculum? A new era of HPV screening

April 22, 2026
NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
Podcast

NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown

April 15, 2026
HHS Secretary Kennedy’s diet advice is heavy on meat and light on scientific consensus
Podcast

HHS Secretary Kennedy’s diet advice is heavy on meat and light on scientific consensus

April 08, 2026

Posts navigation

123…9Next

Trending Stories

  • Charles Rudin named cancer center director at MSK
  • Kennedy calls for a “moonshot” targeted on the role of the microbiome in cancer
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • FDA’s acting drug chief, acting vaccines chief, and chief of staff ousted in the wake of Makary departure
  • Marcel van den Brink: Microbiome research is now in “critical phase” where evidence points to therapeutic use
  • NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account